Baillie Gifford & Co’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-737,152
Closed -$25.5M 497
2022
Q2
$25.5M Sell
737,152
-1,990,058
-73% -$70.2M 0.03% 183
2022
Q1
$120M Sell
2,727,210
-2,411,636
-47% -$117M 0.08% 129
2021
Q4
$323M Buy
5,138,846
+243,565
+5% +$20.7M 0.18% 95
2021
Q3
$516M Buy
4,895,281
+853,991
+21% +$123M 0.27% 82
2021
Q2
$715M Buy
4,041,290
+176,166
+5% +$28.3M 0.35% 76
2021
Q1
$516M Buy
3,865,124
+14,975
+0.4% +$2.32M 0.29% 84
2020
Q4
$521M Buy
3,850,149
+247,713
+7% +$25.2M 0.29% 76
2020
Q3
$300M Buy
3,602,436
+291,954
+9% +$23.4M 0.21% 86
2020
Q2
$272M Buy
3,310,482
+195,682
+6% +$13.2M 0.21% 80
2020
Q1
$160M Buy
3,114,800
+75,100
+2% +$3.91M 0.17% 87
2019
Q4
$126M Sell
3,039,700
-96,400
-3% -$3.56M 0.12% 101
2019
Q3
$101M Buy
3,136,100
+1,049,717
+50% +$36M 0.12% 101
2019
Q2
$72.8M Buy
2,086,383
+2,043,683
+4,786% +$60.2M 0.08% 108
2019
Q1
$1.26M Buy
+42,700
New +$1.17M ﹤0.01% 213

Other funds holding ZLAB

Baillie Gifford & Co's ZLAB Position: Q3 2022 in Review

Baillie Gifford & Co sold out of Zai Lab (ZLAB) in Q3 2022, closing a stake of 737,152 shares — an estimated $25.5M sold.

Baillie Gifford & Co first reported a position in ZLAB in Q1 2019 and held it in 14 quarters. The position peaked at $715M in Q2 2021. 170 funds tracked by Wall St. Rank hold ZLAB as of Q3 2022.

  • Baillie Gifford & Co reported no remaining Zai Lab position as of Q3 2022 after selling out during the quarter.
  • Baillie Gifford & Co sold 737,152 Zai Lab shares in Q3 2022, an estimated $25.5M.
  • Baillie Gifford & Co first reported a position in Zai Lab in Q1 2019 and held it in 14 quarters.
  • Baillie Gifford & Co's Zai Lab position peaked at $715M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Zai Lab as of Q3 2022.

Based on Baillie Gifford & Co's 13F filing for Q3 2022, filed 27 Oct 2022.